Topiramate Tablet
Product Images NDC 70518-0625

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-0625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Topiramate 25mg 70518 0625 00

Topiramate 25mg 70518 0625 00
This is a description of a medication called Topiramate that comes in a 25mg tablet form with a quantity of 30. The medication is manufactured by Cipla USA, Inc. and the NDC number is 70518-0625-00. The directions for use are to be found in the package insert. It should be kept out of reach of children and stored at temperatures between 20-25°C (58-77°F) with some excursions permitted up to 15-30°C (59-86°F) [see USP]. It has been repackaged by RemedyRepack Inc., Indiana, PA 15701, 724.455.8762.*
FDA Label Image

Topiramate 25mg 70518 0625 01

Topiramate 25mg 70518 0625 01
This is a prescription-only medication named Topiramate, which comes in the form of 25mg tablets, and the package contains 30 tablets. The package mentions the NDC number, lot number, and source NDC. The package also offers directions for use and suggests that the medication be stored in a particular temperature range. The medication is repackaged by RemedyRepack Inc. located in Indiana, PA.*
FDA Label Image

Topiramate 25mg 70518 0625 02

Topiramate 25mg 70518 0625 02
This is a description for a medication called Topiramate. It is a 25mg tablet that requires a prescription to obtain. The stock keeping unit (SKU) is identified by the National Drug Code (NDC) number 70518-0625-02 with lot number and expiration date clearly indicated. The medication is manufactured by Cipla USA Inc. located in Miami, Florida. The medication should be kept out of the reach of children and stored within the temperature range of 20-25°C (58-77°F) with permissible excursions to 15-30°C (59-86°F). Directions for use are provided within the package insert. The medication may have been repackaged by RemedyRepack Inc. located in Indiana.*
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02
The text is a chart showing the cumulative seizure rates over time for two different dosages (50 mg/day and 400 mg/day) of a medication called Topiamate.*
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03
The text describes the change in the average monthly migraine period rate during a double-blind phase of a medication called Topamax. The medication comes in two dosages, 100 mg/day and 200 mg/day. The change in monthly migraine rate is shown to be +56, with statistical significance indicated by p-values less than 0.01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.